Legal & General Group
LYRA

Legal & General Group’s LYRA THERAPEUTICS INC LYRA Stock Holding History

Legal & General Group’s Portfolio LYRA Stock Details LYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-15
Closed -$9K – 3583
2021
Q1 		$9K Hold
15
– – ﹤0.01% 3406
2020
Q4 		$9K Buy
15
+7
+88% +$3.94K ﹤0.01% 3367
2020
Q3 		$4K Sell
8
-5
-38% -$3.11K ﹤0.01% 3390
2020
Q2 		$7K Buy
+13
New +$9.5K ﹤0.01% 3357

Other funds holding LYRA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Legal & General Group's LYRA Position: Q2 2021 in Review

Legal & General Group sold out of LYRA THERAPEUTICS INC (LYRA) in Q2 2021, closing a stake of 15 shares — an estimated $9K sold.

Legal & General Group first reported a position in LYRA in Q2 2020 and held it in 4 quarters. The position peaked at $9K in Q1 2021. 44 funds tracked by Wall St. Rank hold LYRA as of Q2 2021.

  • Legal & General Group reported no remaining LYRA THERAPEUTICS INC position as of Q2 2021 after selling out during the quarter.
  • Legal & General Group sold 15 LYRA THERAPEUTICS INC shares in Q2 2021, an estimated $9K.
  • Legal & General Group first reported a position in LYRA THERAPEUTICS INC in Q2 2020 and held it in 4 quarters.
  • Legal & General Group's LYRA THERAPEUTICS INC position peaked at $9K in Q1 2021.
  • 44 funds tracked by Wall St. Rank held LYRA THERAPEUTICS INC as of Q2 2021.

Based on Legal & General Group's 13F filing for Q2 2021, filed 12 Aug 2021.